Platinum open-access journal in cardiovascular medicine. Impact Factor 1.4 CiteScore 1.2 Publishing innovative research with rapid peer review & no author fees
Joined October 2015
- Tweets10.1K
- Following4.2K
- Followers4.1K
- Likes636
Pinned Tweet
Cardiovascular Innovations and Applications (CVIA) achieved a 2025 Journal Impact Factor™ of 2.6, advancing to Q2 in Journal Citation Reports.
Marking the 4th consecutive year of growth. Thanks to our authors, reviewers, Editorial Board & readers.
#ImpactFactor #CardiovascularResearch
#OpenAccess: cvia-journal.org/slug-cvia-i…
6
2,928
This review explores how AI improves CHD diagnosis & prognosis while highlighting the potential of multimodal data integration to improve diagnostic accuracy & personalization. #Cardiology #AI #CoronaryHeartDisease @ZJU_China
#CVIA #OpenAccess: doi.org/10.15212/CVIA.2025.0…
Full article link👇
scienceopen.com/hosted-docum…
13
CVIA Journal retweeted
This review explores how AI improves CHD diagnosis & prognosis while highlighting the potential of multimodal data integration to improve diagnostic accuracy & personalization. #Cardiology #AI #CoronaryHeartDisease @ZJU_China
#CVIA #OpenAccess: doi.org/10.15212/CVIA.2025.0…
CVIA Journal retweeted
#JACCCaseReports case shows that TTVR is feasible & effective in selected elderly high-risk pts w/ severe TR & challenging anatomy. Delayed conduction abnormalities may occur several days after implantation & warrant structured rhythm monitoring.
bit.ly/4iyjZ7C
#vhdTR
ALT This image is an infographic titled "Delayed Emergence: Postoperative Timeline" related to cardiac procedures. The left section details patient cases with severe tricuspid regurgitation treated using Carpentier devices and transcatheter tricuspid valve replacement. The middle section outlines a timeline for delayed emergence, showing postoperative days and various heart conditions. The right section explains the mechanism involving inflammation, atrioventricular block, and pacemaker implantation. At the bottom, a note highlights the importance of extended telemetry in high-risk patients after TTVR.
CVIA Journal retweeted
Are we underestimating aldosterone’s role in resistant hypertension?
🫀 @DrManishNSaxena examines what longer-term findings with aldosterone synthase inhibition add to the debate.
More key evidence from AHA 2026 👉 radc.life/lDRUdllo
#AHA2026 #Hypertension
CVIA Journal retweeted
#WednesdayRead
Temporary mechanical circulatory support in cardiogenic shock: A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute CardioVascular Care (ACVC) of the ESC ow.ly/Fhxw5105HFw
#EHJ
An exploratory study found that DeepSeek-V3.2 and GPT-5.2 produced comparable patient-friendly CMR summaries, supporting AI-assisted communication with clinician oversight.
Check out full article linke here👇
#Cardiology #CVIA #OpenAccess: cvia-journal.org/ai-cmr-repo…
95
This review highlights how miRNAs influence B cells, macrophages & T cells in diabetic cardiomyopathy, identifying potential targets for anti-inflammatory & anti-fibrotic therapies. #Cardiology #DiabeticCardiomyopathy @ShandongU
#CVIA #OpenAccess: doi.org/10.15212/CVIA.2024.0…
74
CVIA Journal retweeted
Explore the challenges associated with simulation deficits in cardiology training and their impact on modern trainees. Gain valuable insights from an in-depth interview between @jhfrudd and Dr Stephen Hamshere of Bart's Hospital, London, as they discuss the role of simulation training in addressing educational gaps and shaping the future of specialist training.
Read the article: bit.ly/4dCVC55
Listen to the podcast: bit.ly/4dCVBy3
CVIA Journal retweeted
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.
ja.ma/4j3bbqq
#ScientificSessions26
CVIA Journal retweeted
🫀 PARAMETRIC MAPPING WEBINAR | T1 MAPPING
📅 Nov 17 | 12–1 PM ET
Refresh your knowledge of T1 mapping—from MR physics & pulse sequences to image acquisition, pitfalls, analysis & clinical reporting.
🔗 Register: learn.scmr.org/URL/Parametri…
#CMR #CardiacMRI #T1MappingA
Effects of Pharmacological and Surgical Treatments on Mitral Regurgitation Regression and Left Heart Structures: A Meta-Analysis . Click the link below to read this #open_access article. scienceopen.com/hosted-docum…
187
Genetic Insights Into the Association Between Sunburn Susceptibility and Thoracic Aortic Aneurysm Through Integrated Genomic and Transcriptomic Analyses . Click the link below to read this #open_access article. scienceopen.com/hosted-docum…
70
Drug Development and Promising Therapeutic Targets for Coronary Artery Disease: Current Landscape and Future Prospects: CVIA State-of-the-Art Review . Click the link below to read this #open_access article. scienceopen.com/hosted-docum…
This study shows that circulating TGM2 is elevated in acute coronary syndrome and strongly associated with myocardial infarction, providing vital prognostic insight for major adverse events when paired with anatomical risk scores.
Click here to read full article - cvia-journal.org/tgm2-progno…
128
This review examines the dynamic trajectory of right ventricular adaptation and failure under chronic pressure overload, highlighting emerging mechanisms, imaging approaches, and therapeutic opportunities in #PulmonaryArterialHypertension. #Cardiology #CVIA #OpenAccess: cvia-journal.org/right-ventr…
1
76
Machine learning-guided analysis of single-cell sequencing data, supported by in vitro validation, identified BTC and KLF15 as candidate diagnostic biomarkers for abdominal aortic aneurysms. #Cardiology #MachineLearning #AbdominalAorticAneurysms @sjtu1896
#CVIA #OpenAccess: doi.org/10.15212/CVIA.2025.0…
👉
💡 IACH Webinar Insights: Beyond the Webinar
How should we manage chemotherapy-induced thrombocytopenia, or CIT, and what is the role of thrombopoietin receptor agonists?
🎙️ Tune in to a new podcast:
on.soundcloud.com/apbfZfPinY…
👩💻 Gain key takeaways from our IACH Webinar:
How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists
iach.org/webinars/
@Mohty_EBMT
1
74
👉
Join #ACCIC Member Section on Thursday, Nov. 12 at 7 p.m. ET for a webinar discussing the latest clinical trials, late-breaking studies and emerging evidence from #TCT2026.
Learn more and register today ➡️ bit.ly/4i55GqL
32
👉
🎙️Two opportunities to hear from Eric Topol, MD, at #ScientificSessions26!
Don't miss the Opening Session as he explores emerging trends and innovations shaping future directions in cardiovascular medicine.
📅 Nov. 7 | 8-8:30 AM CT
📍 Center Stage
Then, join Eric Topol and Joanna Chikwe, MD, FRCS, FAHA, for a live recording of the Ground Truths podcast.
📅 Nov. 8 | 11:30 AM CT
📍Special Session Room
87